(DSY) Dassault Systemes SE - Overview
Stock: 3D Modeling, Simulation, Collaboration, Cloud
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.78% |
| Yield on Cost 5y | 0.73% |
| Yield CAGR 5y | -17.45% |
| Payout Consistency | 98.7% |
| Payout Ratio | 29.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 28.9% |
| Relative Tail Risk | -6.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -2.13 |
| Alpha | -49.13 |
| Character TTM | |
|---|---|
| Beta | 0.056 |
| Beta Downside | 0.059 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.22% |
| CAGR/Max DD | -0.28 |
Description: DSY Dassault Systemes SE January 28, 2026
Dassault Systèmes SE (ticker DSY) is a French-based provider of 3D-modeling, simulation, and collaborative software, most notably the SOLIDWORKS, CATIA, and 3DEXPERIENCE platforms. Its portfolio spans design (SOLIDWORKS, CATIA), simulation (SIMULIA, DELMIA), data intelligence (NETVIBES, MEDIDATA) and cloud infrastructure (OUTSCALE), sold through both direct and partner channels to end-users in industries ranging from aerospace & defense to life sciences and consumer goods.
According to the company’s FY 2023 results (published May 2024), revenue reached €5.1 billion, up 9 % YoY, with operating margin expanding to 22 % (vs. 20 % in FY 2022). Subscription-based recurring revenue now represents roughly 68 % of total sales, and cloud ARR grew 23 % in the latest quarter, reflecting accelerating adoption of the 3DEXPERIENCE SaaS offering.
Key macro drivers underpinning Dassault’s outlook include: (1) a projected 7 % CAGR for the global CAD/PLM market through 2028, fueled by digital-twin adoption in manufacturing and aerospace; (2) rising R&D spend in life-sciences, which drives demand for BIOVIA and simulation tools; and (3) increased capital expenditure in infrastructure and renewable energy, expanding the addressable pool for GEOVIA and ENOVIA solutions. These trends suggest a favorable tailwind for the company’s subscription and cloud-first strategy.
For a deeper quantitative assessment, see the ValueRay model for DSY.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.17b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 0.06 > 1.0 |
| NWC/Revenue: 33.57% < 20% (prev 43.95%; Δ -10.39% < -1%) |
| CFO/TA 0.12 > 3% & CFO 1.65b > Net Income 1.17b |
| Net Debt (-1.32b) to EBITDA (2.02b): -0.66 < 3 |
| Current Ratio: 1.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.32b) vs 12m ago -0.21% < -2% |
| Gross Margin: 82.37% > 18% (prev 0.80%; Δ 8157 % > 0.5%) |
| Asset Turnover: 44.73% > 50% (prev 43.41%; Δ 1.32% > 0%) |
| Interest Coverage Ratio: 19.84 > 6 (EBITDA TTM 2.02b / Interest Expense TTM 74.0m) |
Altman Z'' 5.11
| A: 0.15 (Total Current Assets 5.98b - Total Current Liabilities 3.86b) / Total Assets 14.15b |
| B: 0.57 (Retained Earnings 8.01b / Total Assets 14.15b) |
| C: 0.10 (EBIT TTM 1.47b / Avg Total Assets 14.10b) |
| D: 1.50 (Book Value of Equity 8.79b / Total Liabilities 5.84b) |
| Altman-Z'' Score: 5.11 = AAA |
Beneish M -3.00
| DSRI: 1.10 (Receivables 1.60b/1.40b, Revenue 6.31b/6.10b) |
| GMI: 0.98 (GM 82.37% / 80.46%) |
| AQI: 0.96 (AQ_t 0.52 / AQ_t-1 0.54) |
| SGI: 1.03 (Revenue 6.31b / 6.10b) |
| TATA: -0.03 (NI 1.17b - CFO 1.65b) / TA 14.15b) |
| Beneish M-Score: -3.00 (Cap -4..+1) = A |
What is the price of DSY shares?
Over the past week, the price has changed by -5.58%, over one month by -6.99%, over three months by -8.25% and over the past year by -39.71%.
Is DSY a buy, sell or hold?
What are the forecasts/targets for the DSY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.3 | 35.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 19.2 | -14.1% |
DSY Fundamental Data Overview February 03, 2026
P/E Trailing = 26.6897
P/E Forward = 16.9205
P/S = 4.845
P/B = 3.6314
P/EG = 1.966
Revenue TTM = 6.31b EUR
EBIT TTM = 1.47b EUR
EBITDA TTM = 2.02b EUR
Long Term Debt = 1.15b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.44b EUR (from shortTermDebt, last quarter)
Debt = 2.59b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.32b EUR (from netDebt column, last quarter)
Enterprise Value = 29.25b EUR (30.57b + Debt 2.59b - CCE 3.91b)
Interest Coverage Ratio = 19.84 (Ebit TTM 1.47b / Interest Expense TTM 74.0m)
EV/FCF = 19.86x (Enterprise Value 29.25b / FCF TTM 1.47b)
FCF Yield = 5.04% (FCF TTM 1.47b / Enterprise Value 29.25b)
FCF Margin = 23.35% (FCF TTM 1.47b / Revenue TTM 6.31b)
Net Margin = 18.56% (Net Income TTM 1.17b / Revenue TTM 6.31b)
Gross Margin = 82.37% ((Revenue TTM 6.31b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 78.05% (prev 82.60%)
Tobins Q-Ratio = 2.07 (Enterprise Value 29.25b / Total Assets 14.15b)
Interest Expense / Debt = 2.86% (Interest Expense 74.0m / Debt 2.59b)
Taxrate = 16.57% (54.2m / 327.0m)
NOPAT = 1.22b (EBIT 1.47b * (1 - 16.57%))
Current Ratio = 1.55 (Total Current Assets 5.98b / Total Current Liabilities 3.86b)
Debt / Equity = 0.31 (Debt 2.59b / totalStockholderEquity, last quarter 8.31b)
Debt / EBITDA = -0.66 (Net Debt -1.32b / EBITDA 2.02b)
Debt / FCF = -0.90 (Net Debt -1.32b / FCF TTM 1.47b)
Total Stockholder Equity = 8.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.30% (Net Income 1.17b / Total Assets 14.15b)
RoE = 13.57% (Net Income TTM 1.17b / Total Stockholder Equity 8.63b)
RoCE = 15.02% (EBIT 1.47b / Capital Employed (Equity 8.63b + L.T.Debt 1.15b))
RoIC = 10.98% (NOPAT 1.22b / Invested Capital 11.16b)
WACC = 5.83% (E(30.57b)/V(33.16b) * Re(6.12%) + D(2.59b)/V(33.16b) * Rd(2.86%) * (1-Tc(0.17)))
Discount Rate = 6.12% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.61%
[DCF Debug] Terminal Value 86.51% ; FCFF base≈1.47b ; Y1≈1.49b ; Y5≈1.64b
Fair Price DCF = 38.05 (EV 48.77b - Net Debt -1.32b = Equity 50.09b / Shares 1.32b; r=5.90% [WACC]; 5y FCF grow 1.61% → 2.90% )
EPS Correlation: 43.19 | EPS CAGR: 0.0% | SUE: 0.0 | # QB: 0
Revenue Correlation: 60.25 | Revenue CAGR: 1.76% | SUE: -2.21 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.33 | Chg30d=-0.000 | Revisions Net=-1 | Analysts=6
EPS next Year (2026-12-31): EPS=1.38 | Chg30d=+0.002 | Revisions Net=-4 | Growth EPS=+4.3% | Growth Revenue=+4.4%